Aardvark Therapeutics grants new hire stock option for 60,000 shares at $5.27

• Aardvark Therapeutics granted a new employee a stock option for 60,000 common shares on Oct. 1, 2026.
• Exercise price set at $5.27, matching the stock’s closing price on the grant date.
• Vesting spans four years, with 25% vesting after one year, then monthly vesting of the remainder.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aardvark Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610021605PRIMZONEFULLFEED9838882) on October 02, 2026, and is solely responsible for the information contained therein.